Rakovina Therapeutics Inc.
Symbol: TSXV: RKV
Market Cap: Private
- Selected to join a three-year CDN1.3 million (US$975,000) research program funded by St. Baldrick’s Foundation aimed at developing newtreatments for childhood and adolescent bone cancer
- Presented pre-clinical research results at peer-reviewed scientific meetings
- Received notice of allowance for new patents in Canada, the United States and European Union
- Exciting progress from lead optimization activities being conducted in collaboration with the University of British Columbia